Eduardo Carità

Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder that, with a high mortality rate, usually affects individuals over 60 years of age. The pathology, with inconclusive etiology, presumes that the significant loss of brain composition, could be due to the deposition of TAU proteins in the neuron's microtubules, beta amyloid and the occurrence of peroxidation that leads to exacerbatio…
Development of nanotechnological premix of nanoencapsulated curcumin and marapuama for application in nutraceutical supplements in order to prevent Alzheimer's disease, AP.PIPE
Abstract
Pain is a general term that describes uncomfortable sensations in the body. The International Association for the Study of Pain (IASP) defines pain as "an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage". Indeed, pain is not just a physical sensation. It is influenced by attitudes, beliefs, personality and…
Asclepius - development of a formulation and a drug delivery platform for topical administration in treatment of localized pain, soreness, and inflammation, AP.PIPE
Abstract
According to the World Health Organization (WHO), cardiovascular disease (CVD) is the leading cause of death worldwide and it is estimated more than 17 million deaths from the disease in 2012 (31% of global deaths). EPA and DHA are the main nutraceuticals agents Omega-3, an old acquaintance of the scientific literature on the prevention of risk factors for CVD. Despite their bioactive pro…
Development of nanoparticles for innovative conveying of omega 3 (EPA + DHA) of controlled release in cardiovascular diseases prevention, AP.PIPE

Source:Lattes Curriculum

CV Lattes ORCID

3 / 3	Completed research grants

Associated processes

Short URL

Abstract

Abstract

Abstract